Impact of Resveratrol and Pharmaceutical Care on Type 2 Diabetes Mellitus and Its Neuropathic Complication: A Randomized Placebo Controlled Clinical Trial

Figure 6

Effect of resveratrol with and without pharmaceutical care (PC) on neuropathic symptoms using Douleur Neuropathique 4 (DN4) questions score shown as box and whiskers diagram. Line at median demonstrates DN4 score of the patients with diabetic neuropathic symptoms from day 0 to day 90 of administration of resveratrol with and without pharmaceutical care. Two-way ANOVA repeated measure-mixed model followed by Tukey’s multiple comparison was used for comparison between different groups. value <0.05 was considered statistically significant. <0.05 and <0.0001. # denotes a statistically significant reduction with the baseline. A cutoff value of DN4 ≥4 consider as abnormal. Resv, resveratrol and PC, pharmaceutical care.